feed,title,long_url,short_url
Benzinga,BorgWarner Clocks 7% Sales Decline In Q4; Issues FY22 Outlook,https://benzinga.com/news/earnings/22/02/25631146/borgwarner-clocks-7-sales-decline-in-q4-issues-fy22-outlook,https://bit.ly/3uRP4uk
Benzinga,"The Daily Biotech Pulse: Larimar Plunges On Extension Of Clinical Hold, ImmunityBio Gains On Positive Data, Adcom Test Awaits Avenue Therapeutics",https://benzinga.com/general/biotech/22/02/25630221/the-daily-biotech-pulse-larimar-plunges-on-extension-of-clinical-hold-immunitybio-gains-on-positi,https://bit.ly/3oOwyz6
